ClinConnect ClinConnect Logo
Search / Trial NCT00598910

Effect of Omacor on Triglycerides in HIV Infected Subjects

Launched by SOLVAY PHARMACEUTICALS · Jan 11, 2008

Trial Information

Current as of July 23, 2025

Terminated

Keywords

Hiv Infection

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Triglycerides between 200 and 800
  • diagnosed HIV infection
  • following HAART therapy
  • Exclusion Criteria:
  • other malignant disease
  • not compliant
  • allergy against fish oil
  • soy or olive oil

About Solvay Pharmaceuticals

Solvay Pharmaceuticals is a global biopharmaceutical company dedicated to improving patient health through innovative research and development. As a subsidiary of Solvay, a multinational chemical and advanced materials company, Solvay Pharmaceuticals focuses on delivering transformative therapies across various therapeutic areas, including central nervous system disorders, cardiovascular health, and women's health. Committed to scientific excellence and patient-centric solutions, the company collaborates with healthcare professionals and regulatory bodies to advance clinical trials and bring safe, effective medications to market, ultimately enhancing the quality of life for patients worldwide.

Locations

Bochum, , Germany

Hannover, , Germany

London, , United Kingdom

London, , United Kingdom

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Global Clinical Director Solvay

Study Director

Solvay Pharmaceuticals

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials